These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18286542)

  • 41. Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter.
    Calipari ES; Ferris MJ; Zimmer BA; Roberts DC; Jones SR
    Neuropsychopharmacology; 2013 Nov; 38(12):2385-92. PubMed ID: 23719505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct approach for attenuating cocaine's effects on extracellular dopamine: targeting the dopamine transporter.
    Morgan AE; Porter SP; Clarkson FA; Volkow ND; Fowler JS; Dewey SL
    Synapse; 1997 Aug; 26(4):423-7. PubMed ID: 9215601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.
    Michaelides M; Pascau J; Gispert JD; Delis F; Grandy DK; Wang GJ; Desco M; Rubinstein M; Volkow ND; Thanos PK
    Eur J Neurosci; 2010 Aug; 32(4):668-76. PubMed ID: 20646063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cocaine self-administration in dopamine-transporter knockout mice.
    Rocha BA; Fumagalli F; Gainetdinov RR; Jones SR; Ator R; Giros B; Miller GW; Caron MG
    Nat Neurosci; 1998 Jun; 1(2):132-7. PubMed ID: 10195128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.
    Carboni E; Spielewoy C; Vacca C; Nosten-Bertrand M; Giros B; Di Chiara G
    J Neurosci; 2001 May; 21(9):RC141: 1-4. PubMed ID: 11312315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.
    Wilcox KM; Lindsey KP; Votaw JR; Goodman MM; Martarello L; Carroll FI; Howell LL
    Synapse; 2002 Jan; 43(1):78-85. PubMed ID: 11746736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release.
    Keighron JD; Bonaventura J; Li Y; Yang JW; DeMarco EM; Hersey M; Cao J; Sandtner W; Michaelides M; Sitte HH; Newman AH; Tanda G
    Transl Psychiatry; 2023 Jun; 13(1):202. PubMed ID: 37311803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion.
    Jones JD; Hall FS; Uhl GR; Riley AL
    Pharmacol Biochem Behav; 2010 Feb; 94(4):580-7. PubMed ID: 19969013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Angrist B; Gatley SJ; Logan J; Ding YS; Pappas N
    Am J Psychiatry; 1999 Jan; 156(1):19-26. PubMed ID: 9892293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism.
    Lin Z; Uhl GR
    Mol Pharmacol; 2002 Apr; 61(4):885-91. PubMed ID: 11901228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
    Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
    J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute brain metabolic effects of cocaine in rhesus monkeys with a history of cocaine use.
    Henry PK; Murnane KS; Votaw JR; Howell LL
    Brain Imaging Behav; 2010 Dec; 4(3-4):212-9. PubMed ID: 20680706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.
    Casteels C; Lauwers E; Bormans G; Baekelandt V; Van Laere K
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):124-34. PubMed ID: 17906859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys.
    Kimmel HL; Negus SS; Wilcox KM; Ewing SB; Stehouwer J; Goodman MM; Votaw JR; Mello NK; Carroll FI; Howell LL
    Pharmacol Biochem Behav; 2008 Sep; 90(3):453-62. PubMed ID: 18468667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Redistribution of DAT/α-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease.
    Bellucci A; Navarria L; Falarti E; Zaltieri M; Bono F; Collo G; Spillantini MG; Missale C; Spano P
    PLoS One; 2011; 6(12):e27959. PubMed ID: 22163275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine transporters participate in the physiological regulation of prolactin.
    Demaria JE; Nagy GM; Lerant AA; Fekete MI; Levenson CW; Freeman ME
    Endocrinology; 2000 Jan; 141(1):366-74. PubMed ID: 10614659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
    Zhao G; Li S; Qin GW; Fei J; Guo LH
    J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.
    Volkow ND; Wang GJ; Fowler JS; Fischman M; Foltin R; Abumrad NN; Gatley SJ; Logan J; Wong C; Gifford A; Ding YS; Hitzemann R; Pappas N
    Life Sci; 1999; 65(1):PL7-12. PubMed ID: 10403500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
    Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.
    Volkow ND; Fowler JS; Wang GJ
    J Psychopharmacol; 1999 Dec; 13(4):337-45. PubMed ID: 10667609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.